Skip to main content
. 2019 Nov 20;9:17208. doi: 10.1038/s41598-019-53356-2

Table 2.

Anti-Exenatide antibodies evaluated in plasma at 6 and 12 weeks post subcutaneous Exenatide administration in the form of either PT320 (0.44 or 1.1 mg/kg) or Bydureon (1.1 mg/kg) to nonhuman primates. (+): positive antibody titer; (−): no antibody titer.

Nonhuman primate Anti-Exenatide antibody (1:25)
6 weeks 12 weeks
# 1 (−) (−)
# 2 (−) (−)
# 3 (−) (−)
# 4 (+) (+)
# 5 (−) (−)
# 6 (−) (−)
# 7 (−) (−)
# 8 (−) (−)
# 9 (−) (−)
# 10 (−) (−)
# 11 (−) (−)
# 12 (+) (+)